Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Zero Based Vs Traditional Budgeting For Beginners
Zero Based Budgeting for beginners teaches you to allocate funds from zero, guiding decisions as you build disciplined spending habits and clear priorities.
19,538 articles
BlackLine Stock Down Nearly 30%: What Investors Need Now
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
DSGR (dsgr) 2025 Earnings Call: What Investors Should Do Now
DSGR's Q4 2025 results sparked questions about growth, margins, and 2026 guidance. This deep dive explains what the n...
Stock Market Today, March: Amazon Edges Higher on Zoox
Investors weigh Amazon's Zoox-related progress against UPS's strategic shifts while oil volatility stirs the market. ...
NeoCloud Stocks Skyrocket as IREN, CoreWeave Rally
NeoCloud stocks jumped on renewed AI compute optimism, led by IREN and CoreWeave, while Mara posted strong momentum l...
PureCycle Technologies Stock Sell: Buy After Shay Dump
Shay Capital reduced its PureCycle stake in the latest 13F filing, prompting questions about the stock's future. This...
Remitly Director's $522k Sale: Insider Moves and Insights
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
Rogers Corp. Sells Shares: How to Decide If You Sell
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
Stocks Long-Term Investors Should Buy in May: 2 Top Picks
May often stirs market chatter about seasonal weakness, yet patient investors can find lasting value. Here are two gr...
Worksport (WKSP) 2026 Earnings: Q1 Insights and Outlook
As investors scan early 2026 results, worksport (WKSP) 2026 earnings reveal how a niche hardware maker navigates supp...
Maze Therapeutics Stock Still Climbing After March Tumble
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Why Relay Therapeutics Stock Popped This Wednesday
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status